oral GLP-1s Unlike small molecules, biological therapies such as GLP-1 analogs are administered via weekly subcutaneous or intravenous injections
3 That framing is used to position UNLIMIT as addressing the modifiable portion of aging rather than claiming to alter genetic predisposition, a distinction relevant to how manufacturers might evaluate similar longevity-positioned product lines: the claim rests on a genetics research estimate rather than a demonstrated effect of any specific formula on aging outcomes
Phase Ib/2 Study of Oral Decitabine/Cedazuridine (ASTX727) and Venetoclax in Combination with the Targeted Mutant IDH1 Inhibitor Ivosidenib or the Targeted Mutant IDH2 Inhibitor Enasidenib in IDH Mutated Acute Myeloid Leukemia
Melissa holds specialized expertise in weight management and gut health, and earned her Bachelor of Arts in Nutrition from the College of Saint Benedict, completing her dietetic internship through Iowa State University
A 2022 study found that people who received weekly semaglutide injections lost an average of about 15 pounds after three months
Take our quick 2-minute assessment
